CAS: 1607837-31-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | CCT-251921 REF: 3D-HPC83731CAS: 1607837-31-9 | Min. 95% | A consultar | Lun 03 Mar 25 |
 | CCT-251921 REF: TM-T14901CAS: 1607837-31-9 | 97.74% | 94,00 €~1.049,00 € | Lun 24 Mar 25 |
CCT-251921
CAS:1607837-31-9
CCT-251921 is a molecule that inhibits the activity of cyclin-dependent kinases (CDKs) 4 and 6. …
Fórmula:
C21H23ClN6O
Pureza:
Min. 95%
Peso molecular:
410.9 g/mol
Ref: 3D-HPC83731
| 5mg | 780,00 € | ||
| 10mg | 1.175,00 € | ||
| 25mg | 1.915,00 € | ||
| 50mg | 3.064,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
CCT-251921
CAS:1607837-31-9
CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor (IC50: 2.3 nM).
Fórmula:
C21H23ClN6O
Pureza:
97.74%
Forma y color:
Solid
Peso molecular:
410.9
Ref: TM-T14901
| 1mg | 94,00 € | ||
| 5mg | 218,00 € | ||
| 10mg | 318,00 € | ||
| 25mg | 536,00 € | ||
| 50mg | 768,00 € | ||
| 100mg | 1.049,00 € | ||
| 1mL*10mM (DMSO) | 201,00 € |
Entrega estimada en Estados Unidos, el Lunes 24 de Marzo de 2025
